Theranos and Elizabeth Holmes: SEC, Restitution, Sentence (2026)
Some links pay us a referral fee; each one says so. Disclosure
Update alert · free
An email when the sec fraud cases and investor recoveries numbers change
When a rate, rule or filing behind this page changes: what changed, the one number that matters, and the source to check it yourself.
Quick answer
Elizabeth Holmes founded and ran Theranos, a blood-testing company that the SEC alleged, on March 14, 2018, had raised more than $700 million from investors on false statements; a federal jury convicted her on four counts on January 3, 2022, and a court has ordered her and her co-defendant to repay $452,047,268. That order, dated May 16, 2023, is joint and several: each of them is liable for the whole sum, which covers twelve investors ($397,547,268) plus Walgreens ($40,000,000) and Safeway ($14,500,000). The Ninth Circuit affirmed the convictions, sentences and restitution on February 24, 2025 and amended its opinion on December 22, 2025.
Where she stands as of November 19, 2026: the district court cut her sentence from 135 to 123 months on March 26, 2026, and the Bureau of Prisons inmate locator lists her at the federal prison camp in Bryan with a projected release date of February 22, 2030. The documents we read give no restitution payment schedule and no amount she has paid; the government told the court in 2026 that she had paid minimal restitution.
Key takeaways
- The SEC's March 14, 2018 complaint alleges that Theranos, Holmes and Balwani raised more than $700 million in two financing rounds between late 2013 and 2015. Theranos and Holmes settled without admitting or denying: Holmes agreed to a $500,000 penalty, a 10-year bar from serving as an officer or director of a public company, the return of 18.9 million shares, and the loss of her voting control. The restitution order is about 904 times that penalty (our arithmetic).
- Four different dollar figures sit in the record: more than $700 million raised (SEC), $807,465,307 that the government asked the court to order for all Series C-1 and C-2 investors, $452,047,268 ordered on May 16, 2023, and $120 million of loss found for sentencing in November 2022. They measure different things and none of them is a recovery.
- The jury split on January 3, 2022: four counts of conviction (the investor conspiracy and three wire fraud counts), four acquittals (all patient-related counts), three counts on which it could not agree, and one count dismissed during trial. The wire transfers in the convictions total more than $140 million, according to the U.S. Attorney.
- Holmes was sentenced to 135 months on November 18, 2022; on March 26, 2026 the court reduced her offense level from 33 to 31 under a retroactive amendment and resentenced her to 123 months, which is 10 years and 3 months. Her co-defendant received 155 months on December 7, 2022.
- The Ninth Circuit said the district court should have credited the residual value of the investors' shares but found the error harmless, because the victims were “[un]able to liquidate their shares”. The only returns the record shows are amounts Theranos paid before the order: the court deducted $15,500,000 for Safeway and $46,500,000 for two other investors, $62,000,000 in all (our arithmetic).
- BOP inmate locator on November 19, 2026: Holmes, Bryan (FPC), projected release February 22, 2030; Balwani, Lompoc II (FCI), projected release April 21, 2033. A locator date moves with credits and is not a sentence.
CSV · 61 rows
Theranos and Elizabeth Holmes: SEC complaint, verdict, restitution, appeal and custody, 2018-2026
61 rows: the SEC's terms and share-class facts, the verdict by count, the sentence and its 2026 reduction, every restitution figure, the appeal and the Bureau of Prisons dates. Source and document on every row.
The story, dated
A start-up said a few drops of blood from a finger could run a full range of lab tests. It sold shares to private investors in 2013 and 2014, a drugstore chain and a grocery chain put money in as strategic partners, and the shares never traded on any exchange. The documents below tell what happened to the money after the claims about the technology were tested in court.
| Date | Event | Document |
|---|---|---|
| August 2011 | Safeway wires $30 million to Theranos under convertible notes | Restitution order, May 16, 2023 |
| June 2012 | Walgreens extends a $40 million convertible note | Restitution order, May 16, 2023 |
| Late 2013 | SEC complaint: Theranos has about $30 million of cash and short-term securities; Series C-1 shares are sold to the first investors of the two rounds | SEC complaint ¶44; Ninth Circuit opinion |
| Early 2014 | SEC complaint: a share split and a new Class B with 100 votes per share, given only to Holmes; she holds just over half of the shares and over 99 percent of the votes | SEC complaint ¶¶45-46 |
| 2014 | Series C-2 shares are offered to new investors | Ninth Circuit opinion |
| Late 2017 | SEC complaint: on the verge of bankruptcy, Theranos takes a term loan secured on its patents | SEC complaint ¶94 |
| March 14, 2018 | SEC files fraud complaints against Theranos, Holmes and Balwani; Theranos and Holmes settle | SEC press release 2018-41 |
| June 14, 2018 | A grand jury indicts Holmes and Balwani | U.S. Attorney, N.D. Cal., case page |
| January 3, 2022 | Jury verdict for Holmes: four counts of conviction, four acquittals, three counts without a verdict | Ninth Circuit opinion; U.S. Attorney case page |
| July 7, 2022 | Jury convicts Balwani on all twelve counts | Restitution order, May 16, 2023 |
| November 18, 2022 | Holmes sentenced to 135 months | U.S. Attorney case page |
| December 7, 2022 | Balwani sentenced to 155 months | U.S. Attorney case page |
| May 16, 2023 | Court orders $452,047,268 in restitution, joint and several | Restitution order (Document 1760) |
| May 30, 2023 | Holmes begins serving her sentence | Order of March 26, 2026 |
| February 24, 2025 | Ninth Circuit affirms convictions, sentences and restitution | Ninth Circuit opinion, 129 F.4th 636 |
| December 22, 2025 | Ninth Circuit amends its opinion and denies rehearing | Ninth Circuit amended opinion |
| March 26, 2026 | District court reduces Holmes's sentence to 123 months | Order (Document 1816) |
| November 19, 2026 | BOP locator lists Holmes's projected release as February 22, 2030 | Bureau of Prisons inmate locator |
What the documents show that the headlines don't
The SEC deal and the criminal case were two different cases
On March 14, 2018 the SEC announced that Theranos and Holmes had agreed to resolve its fraud charges and that it would litigate against Balwani in the Northern District of California. The SEC's own press release lists Holmes's terms: “a $500,000 penalty, be barred from serving as an officer or director of a public company for 10 years, return the remaining 18.9 million shares”, and give up her voting control by converting her Class B shares to Class A. Her earlier return of about 34 million shares in the recapitalization (SEC complaint ¶92) brings the shares she handed back to about 52.9 million (our arithmetic). The SEC says Theranos and Holmes neither admitted nor denied the allegations.
The SEC added that, because of the liquidation preference, Holmes would not profit from her shares until “over $750 million” was returned to defrauded investors and other preferred holders, assuming certain warrants were redeemed. That is the first thing for a reader with money to take from the case: in a private company, the order of payment in a sale or liquidation is written into the share terms, and founders can sit behind investors.
The SEC's release for Balwani says only that the claims would be litigated. We found no final judgment in that case among the documents we read.
Four dollar figures, four meanings
| Figure | Amount | What it measures | Source and date |
|---|---|---|---|
| Raised | More than $700 million | What the SEC alleges the company raised in two rounds, late 2013 to 2015 | SEC press release 2018-41, March 14, 2018 |
| Government's request | $807,465,307 plus $40 million (Walgreens) plus $30 million (Safeway) | Full investment of all Series C-1 and C-2 investors, as the government asked | Restitution order, May 16, 2023 |
| Ordered | $452,047,268 | Twelve investors named at sentencing ($397,547,268) and Walgreens and Safeway ($54,500,000), joint and several | Restitution order, May 16, 2023 |
| Sentencing loss | $120 million | Loss found for the sentencing guidelines, which drives the 24-level enhancement | Ninth Circuit opinion, citing the November 2022 findings |
The court ordered 51.5 percent of the government's three largest requests ($452,047,268 against $877,465,307, our arithmetic) because it would not infer from a spreadsheet of investors that every one of them relied on the defendants' statements. Its order says it does “not find the mere fact that an individual or entity had invested in” Theranos enough, and it ordered restitution only for the investors it had identified. The ordered figure is also under 65 percent of the “more than $700 million” the SEC says was raised (our arithmetic: $452,047,268 divided by $700 million, and the SEC figure is a floor).
Who is in the $452,047,268
The court named a total of $397,547,268 for twelve investor-victims and $54,500,000 for two companies. We do not list the individual investors; the order lists each one with the amount.
| Group | Restitution ordered | How the court got there |
|---|---|---|
| Twelve investors named at sentencing | $397,547,268 | Full amount invested, less amounts Theranos had already returned; no deduction for the shares' residual value because none could be sold |
| Walgreens | $40,000,000 | A June 2012 convertible note; the court did not award a further $5 million the government sought for lack of evidence |
| Safeway | $14,500,000 | $30 million wired in August 2011, less $15,500,000 Safeway had already received |
| Total, joint and several | $452,047,268 | Both defendants liable for the entire sum |
The count of victims depends on who is counting. The Ninth Circuit speaks of $452 million “to fourteen victims”, the twelve investors plus the two companies. The district court's March 26, 2026 order describes ten investor-victims identified at sentencing plus Walgreens and Safeway, “for a total of 12”. Both documents give the same $452,047,268.
What was returned, and what was not
The district court credited Theranos's earlier payments to three investors: $3,000,000, $43,500,000 and $15,500,000, which together are $62,000,000 (our arithmetic; the order's footnote 2 lists them as amounts the government did not oppose deducting). Beyond that, the Ninth Circuit summarizes the district court's findings that the investors were not able to sell their shares and that the shares “ultimately became worthless”. The order refers to the company's “eventual dissolution”; we found no document in the record giving a payout to shareholders.
The appeal is the clearest statement of why the order covers whole investments. The Ninth Circuit held the district court “should have also considered possible credits” against the restitution obligation for the residual value of the shares, then found the error harmless because the victims were “[un]able to liquidate their shares” after the fraud came to light, so their actual losses equalled what they invested. It affirmed “the district court's restitution order in its entirety.”
The verdict was not all-or-nothing
Of the twelve counts in the operative indictment, the jury convicted Holmes of four (the investor conspiracy, Count 1, and wire fraud on three investors, Counts 6 to 8), acquitted her of four (the patient conspiracy, Count 2, and patient wire fraud, Counts 10 to 12), could not agree on three (Counts 3 to 5, wire fraud on the early investors), and one count (Count 9) was dismissed during trial. Balwani was tried separately and convicted on all twelve.
| Holmes | Balwani | |
|---|---|---|
| Trial | Verdict January 3, 2022 | Verdict July 7, 2022 |
| Counts of conviction | 4 of 12 | 12 of 12 |
| Original sentence | 135 months (November 18, 2022); no fine | 155 months (December 7, 2022); $25,000 fine |
| Sentence now | 123 months (order of March 26, 2026) | 155 months (no change found in the documents read) |
| BOP facility and projected release, November 19, 2026 | Bryan (FPC); February 22, 2030 | Lompoc II (FCI); April 21, 2033 |
Two sets of company numbers
The SEC complaint says Theranos had about $30 million of cash and short-term securities in late 2013. The Ninth Circuit's summary of trial evidence says that in November 2013 Theranos was down to $15 million in cash and was spending up to $2 million a week. They are different documents with different dates and we give both. The same opinion records trial testimony of net losses of $57 million in 2012 and $92 million in 2013 on no revenue, and says Theranos reported $1,944,948 in total income to the IRS for 2015. The SEC says the company generated a little more than $100,000 of revenue from operations in 2014, against a claim of more than $100 million for that year.
The sentence cut and the release date
On March 26, 2026 the district court found Holmes eligible for the two-level reduction for zero-point offenders in Amendment 821, lowered her offense level from 33 to 31, set a new range of 108 to 135 months and resentenced her to 123 months. The order records her prison record without a disciplinary citation and the government's argument that she “has paid minimal restitution”. It does not state an amount paid.
Counted from May 30, 2023, 123 months runs to August 2033 before any credit (our arithmetic). The Bureau of Prisons locator on November 19, 2026 shows February 22, 2030, about three and a half years earlier, with the actual release date blank. The locator does not say which credits it applies, so we report both and treat the locator date as an estimate that can change.
What this means for your money
This case is about a private company, which means no 10-K, no audited public statements and no price. These are the checks that apply to a private offering or a non-traded fund you are offered.
- Who controls the vote. Class B shares with 100 votes gave one person over 99 percent of the votes while holding just over half of the shares (SEC complaint ¶46). Read the share classes in the offering documents before you read the projections.
- What gets paid first. The liquidation preference meant that more than $750 million had to go back to investors before the founder saw a dollar (SEC press release). In a non-traded REIT, fund or loan, find the same order of payment in the prospectus or offering memorandum.
- A court order is not a payment. The restitution order is $452,047,268; Holmes's SEC penalty was $500,000. The record we read shows deductions for money Theranos had already paid and says nothing about cash received by the investors after the order. Compare with what a trustee actually distributed in another fraud: Madoff's trustee has paid 72.848 percent of allowed claims, and our table of what investors got back in 12 real-estate and private-fund fraud cases shows the usual range.
- Related-party and control terms live in the filing. For a company that did file, the contrast is what WeWork's S-1 showed before its IPO collapsed: the votes, the loans and the leases were all in the document.
- A claim of a partner is checkable. The SEC alleges the company said its devices were used by the Defense Department on the battlefield; the court record has testimony, summarized in the Ninth Circuit's opinion, that the military never installed the device on a medevac or used it to treat servicemembers on the battlefield. When a fund names a famous partner, ask for the agreement.
Do not read this as a verdict on any person beyond what a court or the SEC has recorded. The SEC statements are allegations that Theranos and Holmes did not admit; the criminal convictions are the court's record.
This is analysis of public documents, not investment, legal or tax advice.
FAQ
Sources, read on November 19, 2026: SEC press release 2018-41 and litigation release 24069 (March 2018); SEC complaints SEC v. Holmes et al., 5:18-cv-01602, and SEC v. Balwani, 5:18-cv-01603 (N.D. Cal.); U.S. Attorney's Office, Northern District of California, case page for U.S. v. Elizabeth Holmes, et al. (updated December 12, 2022); United States v. Holmes, 5:18-cr-00258-EJD, Order on Restitution (Document 1760, May 16, 2023) and Order Granting Motion for Modification of Sentence (Document 1816, March 26, 2026), from govinfo.gov; United States Court of Appeals for the Ninth Circuit, Nos. 22-10312 and related, amended opinion filed December 22, 2025 (first filed February 24, 2025); Federal Bureau of Prisons inmate locator (bop.gov), queried November 19, 2026.